New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines
Pharma giant targets new standards of care
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
Originally established in Punjab, the Vasculitis Society of India is now expanding its footprint nationwide
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
The hospital said the new centre will improve access to specialised interventions such as Deep Brain Stimulation
The perinatology CME at Navi Mumbai brought together more than 100 obstetricians, pediatricians, and neonatologists
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
Subscribe To Our Newsletter & Stay Updated
